ArticleOncology research2017

Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death.

Vesna Vetma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.